Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin

Clinical trial NCT06886464 · RECRUITING

Trial details

NCT number: NCT06886464
Sponsor: Matthew James
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury

Start date: 2025-07-16
Primary completion: 2027-12-31
Enrollment: 698

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.